Pharmacokinetic comparison of efanesoctocog alfa vs other EHL-rFVIII products in participants with severe haemophilia A
Sobi.BIVV001-003
Phase 1 other active
Quick answer
Pharmacokinetic comparison of efanesoctocog alfa vs other EHL-rFVIII products in participants with severe haemophilia A for Haemophilia A is a Phase 1 program (other) at Swedish Orphan Biovitrum AB (publ) with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Swedish Orphan Biovitrum AB (publ)
- Indication
- Haemophilia A
- Phase
- Phase 1
- Modality
- other
- Status
- active